The effects of acute and chronic nadolol treatment on β2AR signaling in HEK293 cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 383, Issue 2, 2011, Pages 209-216

  Peng, Hui ^a   Bond, Richard A ^b   Knoll, Brian J ^b  

^a University of Houston   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

2 adrenoceptors; Asthma; CAMP; G s; Inverse agonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; NADOLOL; PHOSPHOSERINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; PKA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; ASTHMA; CELL CULTURE TECHNIQUES; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; LIGANDS; NADOLOL; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 79954448519     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0591-9     Document Type: Article

References (37)

1. 2-adrenergic receptors. Exp Cell Res 313:2586-2596 (Pubitemid 46994705)
2. Baker JG (2005) The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors. Br JPharmacol 144:317-322 (Pubitemid 40313677)
3. Barrios RJ, Kheradmand F, Batts L, Corry DB (2006) Asthma: pathology and pathophysiology. Arch Pathol Lab Med 130:447-451
4. Bond RA, Leff P, Johnson TD, Milano CA, Rockman HA, McMinn TR, Apparsundaram S, Hyek MF, Kenakin TP, Allen LF, Lefkowitz RJ (1995) Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor. Nature 374:272-276
5. Bond RA, Spina D, Parra S, Page CP (2007) Getting to the heart of asthma: can "β-blockers" be useful to treat asthma? Pharmacol Ther 115:360-374 (Pubitemid 47364804)
6. Broadley KJ (2006) β-adrenoceptor responses of the airways: for better or worse? Eur J Pharmacol 533:15-27 (Pubitemid 43340001)
7. Callaerts-Vegh Z, Evans KL, Dudekula N, Cuba D, Knoll BJ, Callaerts PF, Giles H, Shardonofsky FR, Bond RA (2004) Effects of acute and chronic administration of β-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci USA 101:4948-4953 (Pubitemid 38469183)
8. Clark RB, Friedman J, Dixon RAF, Strader CD (1989) Identification of a specific site required for rapid heterologous desensitization of the β-adrenergic receptor by cAMP-dependent protein kinase. Mol Pharmacol 36:343-348 (Pubitemid 19245377)
9. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) β-arrestins and cell signaling. Annu Rev Physiol 69:483-510
10. Drazen JM, Israel E, Boushey HA, Chinchilli VM, Fahy JV, Fish JE, Lazarus SC, Lemanske RF, Martin RJ, Peters SP, Sorkness C, Szefler SJ (1996) Comparison of regularly scheduled with asneeded use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med 335:841-847 (Pubitemid 26304065)
11. Emilien G, Maloteaux JM (1998) Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists. Eur J Clin Pharmacol 53:389-404 (Pubitemid 28154739)
12. FDA (2006) Alert for healthcare professionals-fluticasone propionate; Salmeterol xinafoate (marketed as Advair Diskus)
13. 2- adrenoceptor desensitization and downregulation of Gsα. Br J Pharmacol 132:1261-1270 (Pubitemid 32234710)
14. Foody JM, Farrell MH, Krumholz HM (2002) β-blocker therapy in heart failure: scientific review. JAMA 287:883-889 (Pubitemid 34252037)
15. Gauvreau GM, Jordana M, Watson RM, Cockroft DW, O'Byrne PM (1997) Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med 156:1738-1745 (Pubitemid 28011776)
16. Hanania NA, Singh S, El-Wali R, Flashner M, Franklin AE, Garner WJ, Dickey BF, Parra S, Ruoss S, Shardonofsky F, O'Connor BJ, Page C, Bond RA (2008) The safety and effects of the β-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther 21:134-141
17. 2-adrenoceptor desensitization promotes proasthmatic airway smooth muscle function via PKA/ERK1/2-mediated phosphodiesterase-4 induction. Am J Physiol Lung Cell Mol Physiol 294: L1055-L1067
18. 2-adrenoceptor sites Ser 262 and Ser 355, 356. Br J Pharmacol 147:249-259 (Pubitemid 43214682)
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
20. 2-adrenoceptor and other signaling proteins produced by chronic administration of 'betablockers" in a murine asthma model. Pulm Pharmacol Ther 21:115-124
21. Lipworth BJ, Williamson PA (2009) Think the impossible: betablockers for treating asthma. Clin Sci (Lond) 118:115-120
22. 2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells. Mol Pharmacol 50:1479-1486
23. 2-adrenoceptor-green fluorescent protein fusion proteins. Mol Pharmacol 56:1182-1191
24. 2-adrenoceptor activation. Br J Pharmacol 127:1099-1104 (Pubitemid 29326631)
25. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM (2006) The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129:15-26 (Pubitemid 43265239)
26. Nguyen LP, Omoluabi O, Parra S, Frieske JM, Clement C, Ammar-Aouchiche Z, Ho SB, Ehre C, Kesimer M, Knoll BJ, Tuvim MJ, Dickey BF, Bond RA (2008) Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 38:256-262 (Pubitemid 351567693)
27. Nguyen LP, Lin R, Parra S, Omoluabi O, Hanania NA, Tuvim MJ, Knoll BJ, Dickey BF, Bond RA (2009) β2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A 106:2435-2440
28. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE (2006) Metaanalysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 144:904-912 (Pubitemid 46768131)
29. Seibold A, Williams B, Huang ZF, Friedman J, Moore RH, Knoll BJ, Clark RB (2000) Localization of the sites mediating desensitization of the β2-adrenergic receptor by the GRK pathway. Mol Pharmacol 58:1162-1173
30. Shore SA, Moore PE (2003) Regulation of β-adrenergic responses in airway smooth muscle. Respir Physiol Neurobiol 137:179-195 (Pubitemid 37158008)
31. Smit MJ, Leurs R, Alewijnse AE, Blauw J, Van Nieuw Amerongen GP, Van De Vrede Y, Roovers E, Timmerman H (1996) Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc Natl Acad Sci USA 93:6802-6807 (Pubitemid 26230391)
32. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS (1992) The use of β-agonists and the risk of death and near death from asthma. New Engl J Med 326:501-506
33. Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, Blais L, McNutt M, Buist AS, Spitzer WO (1994) A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists. Am J Respir Crit Care Med 149:604-610
34. Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harre E, Laubscher K, Linscott V, Ramsay CM, Richards G (1998) Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 53:744-752 (Pubitemid 28408714)
35. Tran TM, Friedman J, Qunaibi E, Baameur F, Moore RH, Clark RB (2004) Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the β2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol 65:196-206 (Pubitemid 38113900)
36. Varma DR, Shen H, Deng XF, Peri KG, Chemtob S, Mulay S (1999) Inverse agonist activities of β-adrenoceptor antagonists in rat myocardium. Br J Pharmacol 127:895-902 (Pubitemid 29295348)
37. 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J Biol Chem 267:3530-3538